New research indicates that various features assessed through imaging tests can reveal an individual’s risk of developing meniscus tears, which is one of the most common knee injuries.
Corrected: Sangamo to seek accelerated approval for Fabry gene therapy, claims it won’t need confirmatory study
Sangamo Therapeutics thinks it’s found a faster, earlier pathway to approval for its Fabry disease gene therapy. The biotech announced Tuesday that it plans to
October 23, 2024